Alto Neuroscience, Inc. (ANRO)

Healthcare · Biotechnology · NYSE

Alto Neuroscience, Inc. (ANRO) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.21B and a free-cash-flow yield of -5.8%.

Market cap	$1.21B
Trailing P/E	—
FCF yield	-5.8%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NYSE
Sector	Healthcare
Industry	Biotechnology

Explore live ANRO data on Nama Insights →